Piramal Pharma Solutions Expands Dosage Form Capabilities with Tablet-in-Capsule Technology
Event summary
- Piramal Pharma Solutions successfully developed and commercialized tablet-in-capsule technology at its Pithampur and Ahmedabad sites.
- The project involved a five-month technology transfer between the two sites, demonstrating integrated capabilities.
- Tablet-in-capsule technology allows for flexible dosing options, including modified release drug delivery.
- The technology enables combining incompatible active ingredients into a single capsule, improving medication adherence.
The big picture
Piramal Pharma Solutions' new tablet-in-capsule technology positions it as a leader in flexible, patient-centric drug delivery solutions. This capability is particularly relevant in the context of increasing demand for personalized medicine and complex drug formulations. The successful technology transfer between sites underscores Piramal's integrated operational strengths, which could attract more partnerships in the CDMO space.
What we're watching
- Market Adoption
- How quickly pharmaceutical partners will adopt this technology for their drug development needs.
- Competitive Response
- Whether competitors will introduce similar capabilities, intensifying the CDMO market competition.
- Regulatory Compliance
- The pace at which regulatory approvals will be obtained for products using this technology.
Related topics